These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 22128129

  • 21. A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging.
    Klein SA, Martin H, Schreiber-Dietrich D, Hermann S, Caspary WF, Hoelzer D, Dietrich CF.
    Br J Haematol; 2001 Dec; 115(4):929-34. PubMed ID: 11843829
    [Abstract] [Full Text] [Related]

  • 22. Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT.
    Kirkpatrick ID, Greenberg HM.
    Radiology; 2003 Mar; 226(3):668-74. PubMed ID: 12601214
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic Utility of Endoscopy and Biopsy in Suspected Acute Gastrointestinal Graft-versus-Host Disease after Hematopoietic Progenitor Cell Transplantation.
    Scott AP, Tey SK, Butler J, Kennedy GA.
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1294-1298. PubMed ID: 29410342
    [Abstract] [Full Text] [Related]

  • 24. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy.
    Weisdorf DJ, Snover DC, Haake R, Miller WJ, McGlave PB, Blazar B, Ramsay NK, Kersey JH, Filipovich A.
    Blood; 1990 Aug 01; 76(3):624-9. PubMed ID: 2378989
    [Abstract] [Full Text] [Related]

  • 25. Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).
    Castilla C, Pérez-Simón JA, Sanchez-Guijo FM, Díez-Campelo M, Ocio E, Pérez-Persona E, López-Villar O, Vazquez L, Caballero D, San Miguel JF.
    Biol Blood Marrow Transplant; 2006 Sep 01; 12(9):936-41. PubMed ID: 16920559
    [Abstract] [Full Text] [Related]

  • 26. Severe acute gastrointestinal graft-vs-host disease: an emerging surgical dilemma in contemporary cancer care.
    Irani JL, Cutler CS, Whang EE, Clancy TE, Russell S, Swanson RS, Ashley SW, Zinner MJ, Raut CP.
    Arch Surg; 2008 Nov 01; 143(11):1041-5; discussion 1046. PubMed ID: 19015460
    [Abstract] [Full Text] [Related]

  • 27. Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy.
    Cho BS, Yahng SA, Kim JH, Yoon JH, Shin SH, Lee SE, Choi SM, Lee DG, Eom KS, Park G, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW.
    Ann Hematol; 2013 Apr 01; 92(4):497-504. PubMed ID: 23180439
    [Abstract] [Full Text] [Related]

  • 28. 18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD).
    Roll W, Schindler P, Masthoff M, Strotmann R, Albring J, Reicherts C, Weckesser M, Noto B, Stelljes M, Schäfers M, Evers G.
    BMC Cancer; 2021 Sep 10; 21(1):1015. PubMed ID: 34507549
    [Abstract] [Full Text] [Related]

  • 29. Computed tomography imaging of acute gastrointestinal graft-versus-host disease after haematopoietic stem cell transplantation in children.
    Arpaci T.
    Contemp Oncol (Pozn); 2018 Sep 10; 22(3):178-183. PubMed ID: 30455590
    [Abstract] [Full Text] [Related]

  • 30. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
    Bhutani D, Dyson G, Manasa R, Deol A, Ratanatharathorn V, Ayash L, Abidi M, Lum LG, Al-Kadhimi Z, Uberti JP.
    Biol Blood Marrow Transplant; 2015 Jan 10; 21(1):159-64. PubMed ID: 25445637
    [Abstract] [Full Text] [Related]

  • 31. Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
    Ganetsky A, Frey NV, Hexner EO, Loren AW, Gill SI, Luger SM, Mangan JK, Martin ME, Babushok DV, Drobyski WR, Smith J, Timlin C, Freyer CW, Stadtmauer EA, Porter DL.
    Bone Marrow Transplant; 2019 Feb 10; 54(2):212-217. PubMed ID: 29795429
    [Abstract] [Full Text] [Related]

  • 32. The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review.
    Wild D, Sung AD, Cardona D, Cirricione C, Sullivan K, Detweiler C, Shealy M, Balmadrid B, Rowes KL, Chao N, Piryani S, Karimabad HM, Martin P, Poleski M.
    Dig Dis Sci; 2016 Mar 10; 61(3):806-13. PubMed ID: 26537485
    [Abstract] [Full Text] [Related]

  • 33. The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.
    Sakellari I, Batsis I, Bousiou Z, Mallouri D, Constantinou V, Gavriilaki E, Smias C, Yannaki E, Kaloyannidis P, Papaioannou G, Stavroyianni N, Syrigou A, Sotiropoulos D, Fylaktou A, Tsompanakou A, Saloum R, Anagnostopoulos A.
    Clin Lymphoma Myeloma Leuk; 2017 Oct 10; 17(10):658-666. PubMed ID: 28716402
    [Abstract] [Full Text] [Related]

  • 34. Terminal ileum is the most sensitive site for the histologic diagnosis of grade 4 graft-versus-host disease (GvHD) in the lower GI tract and is a harbinger of poor outcome.
    Yip RHL, Naso JR, Yang HM.
    Virchows Arch; 2021 Nov 10; 479(5):919-925. PubMed ID: 34131796
    [Abstract] [Full Text] [Related]

  • 35. Helicobacter pylori infection and graft-versus-host disease.
    Velasco Guardado A, López-Corral L, Pérez-Simón JA, Caballero-Velázquez T, Flores Corral T, Caballero Barrigón D, Rodríguez Pérez A.
    Biol Blood Marrow Transplant; 2011 May 10; 17(5):765-9. PubMed ID: 21093601
    [Abstract] [Full Text] [Related]

  • 36. Parametric Imaging of Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Acute Gastrointestinal Graft-Versus-Host Disease.
    Pausch AM, Kammerer S, Weber F, Herr W, Stroszczynski C, Holler E, Edinger M, Wolff D, Weber D, Jung EM, Wertheimer T.
    Cells; 2021 May 03; 10(5):. PubMed ID: 34063640
    [Abstract] [Full Text] [Related]

  • 37. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
    Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, Gallagher G, Kerr H, Kuruvilla J, Lee SJ, Moore J, Nevill T, Popradi G, Roy J, Schultz KR, Szwajcer D, Toze C, Foley R, Cell Therapy Transplant Canada.
    Lancet Haematol; 2020 Feb 03; 7(2):e100-e111. PubMed ID: 31958417
    [Abstract] [Full Text] [Related]

  • 38. What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score.
    MacMillan ML, DeFor TE, Weisdorf DJ.
    Br J Haematol; 2012 Jun 03; 157(6):732-41. PubMed ID: 22486355
    [Abstract] [Full Text] [Related]

  • 39. Indium-111-labeled autologous leukocyte scanning in gastrointestinal graft versus host disease (GVHD).
    Saverymuttu SH, Peters AM, O'Brien C, Chadwick VS, Lavender JP, Goldman JM, Gordon-Smith EC, Hodgson HJ.
    Dig Dis Sci; 1986 Aug 03; 31(8):829-32. PubMed ID: 3089743
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Remberger M, Kumlien G, Aschan J, Barkholt L, Hentschke P, Ljungman P, Mattsson J, Svennilson J, Ringdén O.
    Biol Blood Marrow Transplant; 2002 Aug 03; 8(12):674-82. PubMed ID: 12523580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.